INSM Dec 2025 110.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 09:31AM EDT. Market open.
| Previous Close | 6.63 |
| Open | N/A |
| Bid | 4.60 |
| Ask | 6.70 |
| Strike | 110.00 |
| Expire Date | 2025-12-19 |
| Day's Range | 6.63 - 6.63 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
ZacksInsmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR NewswireInsmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its third-quarter 2024 financial results on Thursday, October 31, 2024.
GuruFocus.comInsmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Insmed Inc (INSM) reports robust financial performance and outlines strategic initiatives for upcoming product launches amid competitive challenges.
© 2024 Yahoo. All rights reserved.